Afuco™ Anti-Human TFPI ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TFPI ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are used for treatment of genetic and acquired deficiencies or defects in coagulation such as hemophilia A and B.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-580CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TFPI |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |